ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
Cancer
; 126(24): 5303-5310, 2020 12 15.
Article
em En
| MEDLINE
| ID: mdl-32914879
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Rabdomiossarcoma
/
Blastoma Pulmonar
/
Neurofibrossarcoma
/
Sarcoma Sinovial
/
Tumor de Wilms
/
Maitansina
/
Anticorpos Monoclonais
/
Neuroblastoma
Tipo de estudo:
Prognostic_studies
Limite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Cancer
Ano de publicação:
2020
Tipo de documento:
Article